452 companies

Birzeit Pharmaceuticals

Market Cap: US$141.5m

Manufactures and trades in various medicines in the Palestinian Authority.

BPC

US$3.65

7D

1.4%

1Y

-13.7%

Rallybio

Market Cap: US$26.2m

A clinical-stage biotechnology company, engages in development and commercialization of life-transforming therapies for patients suffering from severe and rare diseases.

RLYB

US$0.64

7D

-3.7%

1Y

-60.6%

Shanghai Fudan-Zhangjiang Bio-PharmaceuticalLtd

Market Cap: HK$7.2b

Engages in the research, development, manufacture, and sale of bio-pharmaceutical products in the People's Republic of China.

1349

HK$2.74

7D

3.8%

1Y

20.2%

Blueberries Medical

Market Cap: CA$4.0m

Engages in the growth, cultivation, and development of medicinal cannabis and related products in Colombia.

BBM

CA$0.01

7D

-33.3%

1Y

-60.0%

Simply Better Brands

Market Cap: CA$103.7m

Operates as an omni-channel platform with diversified assets in the plant-based and wellness consumer product categories.

SBBC

CA$1.01

7D

0%

1Y

159.0%

Aadi Bioscience

Market Cap: US$48.8m

A biopharmaceutical company, engages in developing and commercializing precision therapies for genetically defined cancers with alterations in mTOR pathway genes.

AADI

US$2.10

7D

8.8%

1Y

-0.9%

InnoCan Pharma

Market Cap: CA$60.9m

A pharmaceutical technology company, focuses on the development of various drug delivery platforms combining cannabidiol (CBD) with other pharmaceutical ingredients in the United States, Canada, Europe, and internationally.

INNO

CA$0.20

7D

0%

1Y

-32.2%

NervGen Pharma

Market Cap: CA$191.2m

Engages in the discovery, development, and commercialization of pharmaceutical treatments for medical conditions related to nervous system damage.

NGEN

CA$2.75

7D

-1.4%

1Y

12.7%

ALT5 Sigma

Market Cap: US$65.3m

Operates a next generation blockchain platform.

ALTS

US$4.52

7D

-4.2%

1Y

60.9%

Nuo Therapeutics

Market Cap: US$63.0m

A regenerative therapies company, develops, commercializes, and markets cell-based technologies that harness the regenerative capacity of the human body to trigger natural healing in the United States.

AURX

US$1.35

7D

-0.3%

1Y

49.6%

Hamlet BioPharma

Market Cap: SEK 728.5m

Engages in the development of drugs for the treatment and prevention of cancer in Sweden.

HAMLET B

SEK 4.10

7D

-3.3%

1Y

101.0%

Abliva

Market Cap: SEK 715.7m

Abliva AB (publ) discovers and develops medicines for the treatment of mitochondrial disease in Sweden.

ABLI

SEK 0.44

7D

-1.1%

1Y

196.0%

Telescope Innovations

Market Cap: CA$19.6m

A chemical technology company, develops manufacturing processes and tools for the pharmaceutical and chemical industry in the United States and Canada.

TELI

CA$0.36

7D

-8.8%

1Y

-3.9%

180 Life Sciences

Market Cap: US$3.4m

A clinical stage biotechnology company, focuses on developing therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases.

ATNF

US$1.07

7D

-5.3%

1Y

-68.3%

Hexima

Market Cap: AU$2.2m

Does not have significant operations.

HXL

AU$0.013

7D

0%

1Y

-18.8%

Autolus Therapeutics

Market Cap: US$497.6m

A clinical-stage biopharmaceutical company, develops T cell therapies for the treatment of cancer and autoimmune diseases.

AUTL

US$1.82

7D

-6.2%

1Y

-70.7%

Cytophage Technologies

Market Cap: CA$9.4m

A biotechnology company, engages in the research, development, and commercialization bacteriophage therapies to treat bacterial infections affecting human health, animal health, and food security in Canada.

CYTO

CA$0.17

7D

-8.1%

1Y

-64.6%

CASI Pharmaceuticals

Market Cap: US$34.5m

A biopharmaceutical company, develops and commercializes therapeutics and pharmaceutical products in the People’s Republic of China, the United States, and internationally.

CASI

US$2.26

7D

0.9%

1Y

-25.4%

Seer

Market Cap: US$116.6m

A life sciences company, engages in developing and commercializing products to decode the biology of the proteome.

SEER

US$1.94

7D

1.6%

1Y

2.6%

Harvard Apparatus Regenerative Technology

Market Cap: US$35.5m

A clinical-stage biotechnology company, focuses on developing regenerative-medicine treatments for disorders of the gastro-intestinal system and other organs resulting from cancer, trauma, or birth defects.

HRGN

US$2.23

7D

-9.1%

1Y

-28.1%

Proteomics International Laboratories

Market Cap: AU$64.2m

Operates as a medical technology company with a focus on the area of proteomics in Australia, New Zealand, the United States, Europe, India, and South East Asia.

PIQ

AU$0.49

7D

2.1%

1Y

-48.1%

Zhejiang Yatai Pharmaceutical

Market Cap: CN¥2.5b

Researches, produces, sells, and exports pharmaceutical products in China and internationally.

002370

CN¥3.45

7D

3.6%

1Y

-5.2%

ImmuCell

Market Cap: US$44.5m

An animal health company, develops, manufactures, and sells products that enhance the health and productivity of dairy and beef cattle in the United States and internationally.

ICCC

US$4.97

7D

2.1%

1Y

-0.4%

Malaysian Genomics Resource Centre Berhad

Market Cap: RM 35.7m

An investment holding company, provides genetics, genomics, immunotherapy, and biopharmaceutical services worldwide.

MGRC

RM 0.26

7D

2.0%

1Y

-40.9%

Inhibitor Therapeutics

Market Cap: US$12.1m

A pharmaceutical development company, develops and commercializes therapeutics for patients with certain cancers and non-cancerous proliferation disorders in the United States.

INTI

US$0.07

7D

0.7%

1Y

0%

Imugene

Market Cap: AU$261.0m

A clinical stage immuno-oncology company, develops a range of immunotherapies to activate the immune system of cancer patients to treat and eradicate tumours in Australia.

IMU

AU$0.035

7D

0%

1Y

-68.2%

Incannex Healthcare

Market Cap: US$13.2m

A clinical-stage biopharmaceutical company, engages in the research, development, manufacture, sale, and distribution of psychedelic medicines and therapies for patients with chronic diseases in Australia.

IXHL

US$0.74

7D

-5.1%

1Y

-79.2%

Intensity Therapeutics

Market Cap: US$35.0m

A clinical-stage biotechnology company, engages in the discovery, development, and commercialization of cancer drugs in the United States.

INTS

US$2.24

7D

0.4%

1Y

-53.8%

Pila Pharma

Market Cap: SEK 95.2m

PILA PHARMA AB (publ) operates as a clinical stage pharmaceutical company in Sweden.

PILA

SEK 3.51

7D

1.7%

1Y

188.9%

Tiziana Life Sciences

Market Cap: US$169.1m

A biotechnology company, focuses on the discovery and development of molecules to treat human diseases in oncology and immunology in the United States.

TLSA

US$1.55

7D

13.1%

1Y

216.3%

Renovaro

Market Cap: US$127.8m

A pre-clinical stage biotechnology company, engages in the development of pharmaceutical and biological products for the treatment of cancer and HIV in the United States and the Netherlands.

RENB

US$0.77

7D

-11.5%

1Y

-74.4%

Vitura Health

Market Cap: AU$48.3m

Engages in the sale and distribution of medicinal cannabis products in Australia.

VIT

AU$0.073

7D

4.3%

1Y

-51.3%

Orthocell

Market Cap: AU$328.7m

A regenerative medicine company, develops and commercializes cell therapies and biological medical devices for the repair of various bone and soft tissue injuries in Australia, the United States, the United Kingdom, and the European Union.

OCC

AU$1.37

7D

9.2%

1Y

251.3%

Viva Biotech Holdings

Market Cap: HK$4.1b

An investment holding company, engages in the provision of structure-based drug discovery services to biotechnology and pharmaceutical customers worldwide.

1873

HK$1.95

7D

42.3%

1Y

261.1%

AbCellera Biologics

Market Cap: US$750.9m

AbCellera Biologics Inc. builds an engine for antibody drug discovery and development.

ABCL

US$2.54

7D

15.5%

1Y

-44.7%

PharmaTher Holdings

Market Cap: CA$17.7m

A specialty pharmaceutical company, develops and commercialize specialty pharmaceuticals exhibiting the adoption and permitting novel delivery methods to enhance patient outcomes.

PHRM

CA$0.20

7D

7.9%

1Y

-41.4%

Page 12 of 13